首页 文献索引 SCI期刊 AI助手
条件筛选
相关性 最新发表 最早发表
全文 标题 期刊 作者
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
模糊 精准
{{tag.shortname||tag.name}}:{{getFilterLabel(field)}} Clear All
Niraj Kumar Srivastava,Nikhil Pandey,Janki Makani et al. Niraj Kumar Srivastava et al.
Background: Dengue virus (DENV) has emerged as a significant cause of neurological complications, including movement disorders, which fall under the broader category of neurological manifestations associated with DENV inf...
Akhmad Irfan Alfiyan,Agustina Sus Andreani,Tien Setyaningtyas et al. Akhmad Irfan Alfiyan et al.
The results showed that AuNPs-mAb can detect dengue virus in 1 minute (ultrafast). This can be seen from the absorbance change of 0.296, the wavelength shifted to 526 nm, and the color change of the solution from slightly purplish to faint purple.
Andrew S Browne,Jieqiong Fang,Amany Elsharkawy et al. Andrew S Browne et al.
Early detection and monitoring of dengue virus (DENV) infections are critical for effective disease management. A comprehensive approach combining viral and host biomarker detection improves diagnostic accuracy.
Nicholas K Hurlburt,Jay Lubow,Leslie Goo et al. Nicholas K Hurlburt et al.
Safe and effective vaccines against co-circulating mosquito-borne orthoflaviviruses such as Zika virus (ZikV) and the four serotypes of dengue virus (DenV1-4) must elicit broadly neutralizing antibodies (bnAbs) to prevent the risk of enhancement of infection by non-neutralizing antibodies.
Manuel Sanchez-Landers,Arnold Frank Rodriguez-Benites Manuel Sanchez-Landers
We present the case of a woman from an area endemic for dengue with Guillain-Barré syndrome with a disability scale of 4/6 on the Hughes scale, confirmed by albumin-cytological dissociation, and previous infection with dengue virus confirmed with a positive serum ELISA IgM test.
Juliana Schons Gularte,Daisy Maria Strottmann,Fernando Rosado Spilki et al. Juliana Schons Gularte et al.
It is caused by the dengue virus (DENV), which comprises four antigenically distinct serotypes. The clinical manifestations of the disease overlap with those of other febrile diseases, including other arboviruses such as Zika and chikungunya, making clinical and epidemiological diagnosis difficult.
Daniel Camprubí-Ferrer,Brenda Torres-Velásquez,Janice Perez Padilla et al. Daniel Camprubí-Ferrer et al.
Although many dengue virus (DENV) infections are asymptomatic or produce only mild illness, DENV can occasionally cause severe and fatal disease.
Fousseyni Kane,Yacouba Cissoko,John Collins et al. Fousseyni Kane et al.
Dengue fever, a vector-borne disease caused by four serotypes of dengue virus (DENV), ranges from asymptomatic to severe illness, including hemorrhagic fever and shock syndrome....The successful sequencing of 19 samples revealed dengue virus serotype 3 (DENV-3; genotype III) in 15 (65.21%) samples and dengue virus serotype 1 (DENV-1; genotype III) in 4 (17.39%) samples.
Thanh T N Phan,Devina J Thiono,Matthew G Hvasta et al. Thanh T N Phan et al.
The four serotypes of dengue virus (DENV1-4) are a major health concern putting 50% of the global population at risk of infection.
Margarette C Mariano,Helen S Jung,Olivia Vergnolle et al. Margarette C Mariano et al.
Dengue virus (DENV) is a mosquito-transmitted flavivirus; there are four serotypes (DENV1-4) that co-circulate globally. Primary infection causes self-limiting febrile illness, but secondary infection by a heterologous serotype can predispo...
耗时 0.15576 秒,为您在 48229835 条记录里面共找到 10000 篇文章 [XML]